Orkin Aaron M, McArthur Allison, McDonald André, Mew Emma J, Martiniuk Alexandra, Buchman Daniel Z, Kouyoumdjian Fiona, Rachlis Beth, Strike Carol, Upshur Ross
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Schwartz/Reisman Emergency Medicine Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
BMJ Open. 2018 Aug 1;8(7):e021172. doi: 10.1136/bmjopen-2017-021172.
Task shifting interventions are intended to both deliver clinically effective treatments to reduce disease burden and address health inequities or population vulnerability. Little is known about how health equity and population vulnerability are defined and measured in research focused on task shifting. This systematic review will address the following questions: Among task shifting interventions in high-income settings that have been studied using randomised controlled trials or variants, how are health inequity or population vulnerability identified and defined? What methods and indicators are used to describe, characterise and measure the population's baseline status and the intervention's impacts on inequity and vulnerability?
Studies were identified through database searches (MEDLINE, Embase, CINAHL, PsycINFO and Web of Science). Eligible studies will be randomised controlled trials published since 2004, conducted in high-income countries, concerning task shifting interventions to treat any disease, in any population that may face health disadvantage as defined by the PROGRESS-Plus framework (place of residence, race/ethnicity/culture/language, occupation, gender/sex, religion, social capital, socioeconomic position, age, disability, sexual orientation, other vulnerable groups). We will conduct independent and duplicate title and abstract screening, then identify related papers from the same programme of research through further database and manual searching. From each programme of research, we will extract study details, and definitions and measures of health equity or population vulnerability based on the PROGRESS-Plus framework. Two investigators will assess the quality of reporting and measurement related to health equity and vulnerability using a scale developed for this study. A narrative synthesis will highlight similarities and differences between the gathered studies and offer critical analyses and implications.
This review does not involve primary data collection, does not constitute research on human subjects and is not subject to additional institutional ethics review or informed consent procedures. Dissemination will include open-access peer-reviewed publication and academic conference presentations.PROSPERO Registration Number CRD42017049959.
任务转移干预旨在提供临床有效的治疗方法,以减轻疾病负担,并解决健康不平等或人群脆弱性问题。在专注于任务转移的研究中,对于如何定义和衡量健康公平性和人群脆弱性知之甚少。本系统综述将解决以下问题:在高收入环境中使用随机对照试验或变体进行研究的任务转移干预措施中,如何识别和定义健康不平等或人群脆弱性?使用哪些方法和指标来描述、表征和衡量人群的基线状态以及干预措施对不平等和脆弱性的影响?
通过数据库检索(MEDLINE、Embase、CINAHL、PsycINFO和科学网)确定研究。符合条件的研究将是2004年以来发表的随机对照试验,在高收入国家进行,涉及治疗任何疾病的任务转移干预措施,针对任何可能面临由PROGRESS-Plus框架定义的健康劣势的人群(居住地点、种族/族裔/文化/语言、职业、性别/性取向、宗教、社会资本、社会经济地位、年龄、残疾、性取向、其他弱势群体)。我们将进行独立和重复的标题和摘要筛选,然后通过进一步的数据库和手动检索,从同一研究项目中识别相关论文。从每个研究项目中,我们将提取研究细节,以及基于PROGRESS-Plus框架的健康公平性或人群脆弱性的定义和衡量方法。两名研究人员将使用为本研究开发的量表评估与健康公平性和脆弱性相关的报告和测量质量。叙述性综合将突出所收集研究之间的异同,并提供批判性分析和启示。
本综述不涉及原始数据收集,不构成对人类受试者的研究,也无需额外的机构伦理审查或知情同意程序。传播将包括开放获取的同行评审出版物和学术会议报告。PROSPERO注册号CRD42017049959。